Option Care Health (BMV:OPCH *) - Stock Price, News & Analysis

OPCH * Stock Overview

Offers home and alternate site infusion services in the United States.

OPCH * fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 40.3% below our estimate of its fair value

Earnings are forecast to grow 10.23% per year

Analysts in good agreement that stock price will rise by 26.4%

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Option Care Health, Inc. Competitors

CorVel

NasdaqGS:CRVL

US$5.4b

Dr. Lal PathLabs

NSEI:LALPATHLAB

₹275.8b

Chemed

NYSE:CHE

US$8.7b

Amedisys

NasdaqGS:AMED

US$3.2b

Price History & Performance

Summary of all time highs, changes and price drops for Option Care Health
Historical stock prices
Current Share Price	US$601.10
52 Week High	US$601.10
52 Week Low	US$576.89
Beta	1.29
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	4.20%

Recent updates

Shareholder Returns

	OPCH *	MX Healthcare	MX Market
7D	4.2%	5.5%	0.06%
1Y	n/a	-8.5%	2.2%

Return vs Industry: Insufficient data to determine how OPCH * performed against the MX Healthcare industry.

Return vs Market: Insufficient data to determine how OPCH * performed against the MX Market.

Price Volatility

Is OPCH *'s price volatile compared to industry and market?
OPCH * volatility
OPCH * Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.2%
Market Average Movement	4.4%
10% most volatile stocks in MX Market	6.3%
10% least volatile stocks in MX Market	2.9%

Stable Share Price: OPCH * has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine OPCH *'s volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	6,806	John Rademacher	www.optioncarehealth.com

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.

Option Care Health, Inc. Fundamentals Summary

How do Option Care Health's earnings and revenue compare to its market cap?
OPCH * fundamental statistics
Market cap	Mex$102.00b
Earnings (TTM)	Mex$3.99b
Revenue (TTM)	Mex$86.75b

25.1x

P/E Ratio

1.2x

P/S Ratio

Is OPCH * overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OPCH * income statement (TTM)
Revenue	US$4.59b
Cost of Revenue	US$3.60b
Gross Profit	US$989.25m
Other Expenses	US$777.94m
Earnings	US$211.31m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.24
Gross Margin	21.55%
Net Profit Margin	4.60%
Debt/Equity Ratio	78.8%

How did OPCH * perform over the long term?

See historical performance and comparison

Option Care Health BMV:OPCH * Stock Report